The latest Omicron variant of COVID has created a lot of anxiety globally. The World Health Organization (WHO) has designated it as a ‘variant of concern’ and steps are being taken internationally to contain the Omicron infections. While the healthcare experts continue their research to learn more about this variant, Ubiqare Health addresses commonly asked questions about symptoms, treatment options, etc.
Ubiqare Health is selected as a finalist for its unique platform and business model that combine telemedicine, digital specialty care and last-mile clinical network. The Ubiqare model not only connects specialized medical expertise to remote patients, but also creates new livelihoods for distributed healthcare workers living in proximity to the patients at home. This network of healthcare workers, nurses and doctors augments the capacity to deliver physical care and can be scaled as per needs.
Breast cancer as an illness is mostly associated with women. However, it can affect men also. Although the relative percentage of incidence is low, a study published in JAMA Oncology shows that the mortality rate in men breast cancer is 19% higher than in women.
Cancer is a complex illness that often leaves the patient and the family overwhelmed. In the hospital,
they have the guidance of the medical staff. The real challenge starts on discharge from the hospital
when they need follow-up care. This is where a Cancer Care Navigator can help a great deal.
Highlighting tech-enabled care as a differentiator, the article talked about patients requiring long-term care away from hospital. It talked about how Ubiqare Health’s tech-enabled care model can be helpful for chronic patients who after getting discharged from the hospital try to recuperate at home but continue to suffer from side effects.